首页> 美国卫生研究院文献>Critical Care >Rapid molecular detection of methicillin-resistant Staphylococcus aureus: a cost-effective tool for infection control in critical care?
【2h】

Rapid molecular detection of methicillin-resistant Staphylococcus aureus: a cost-effective tool for infection control in critical care?

机译:快速耐甲氧西林金黄色葡萄球菌分子检测:一种在重症监护中控制感染的经济有效工具?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Control strategies for methicillin-resistant Staphylococcus aureus (MRSA) in critical care remain debated. Timely detection of MRSA carriers is crucial to an effective isolation policy. In this issue, Harbarth and colleagues report rapid MRSA screening among intensive care unit-admitted patients using a PCR assay. Preemptive isolation for all admissions until screened negative for MRSA was associated with a reduction of intensive care unit-acquired MRSA infections in one of two study units. The data provide preliminary evidence to the effectiveness of a MRSA control strategy combining rapid screening by a molecular method and preventive isolation. Further controlled studies are needed to evaluate the cost-effectiveness of this intervention.
机译:重症监护中耐甲氧西林金黄色葡萄球菌(MRSA)的控制策略仍存在争议。及时检测MRSA载波对于有效的隔离策略至关重要。在本期杂志中,Harbarth及其同事报告了使用PCR测定法在接受重症监护病房的患者中进行的快速MRSA筛查。在两个研究单位之一中,对所有入院患者进行先发隔离,直到筛查MRSA阴性为止与减少重症监护室获得性MRSA感染有关。数据为通过分子方法快速筛选和预防性隔离相结合的MRSA控制策略的有效性提供了初步证据。需要进一步的对照研究来评估这种干预措施的成本效益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号